why choose us

First received: October 18, 2023

Clinical Trial: Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Oral Cavity Squamous Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Phase I/IIa, Single-Arm, Dose-Confirmation and Dose-Expansion Study Evaluating Changes in the Oral Microbiome of Patients With Oral Cavity Squamous Cell Carcinoma (OSCC) After Short-Term Ingest

Brief Summary: This is a study of oral nisin administration in patients with OSCC who are undergoing complete surgical resection surgery with or without adjuvant radiation/chemoradiation as part of their routine care at the University of California, San Francisco (UCSF).

Read more